Clinical outcome of combination of vancomycin and ceftaroline versus vancomycin monotherapy for treatment of methicillin resistant Staphylococcus aureus bloodstream infection.

MLA

Waked, Rami, et al. “Clinical Outcome of Combination of Vancomycin and Ceftaroline versus Vancomycin Monotherapy for Treatment of Methicillin Resistant Staphylococcus Aureus Bloodstream Infection.” BMC Infectious Diseases, vol. 24, no. 1, Oct. 2024, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s12879-024-10107-7.

APA

Waked, R., Coats, L., Rosato, A., Yen, C. F., Wood, E., Diekema, D. J., Rokas, K. E., & Mercuro, N. J. (2024). Clinical outcome of combination of vancomycin and ceftaroline versus vancomycin monotherapy for treatment of methicillin resistant Staphylococcus aureus bloodstream infection. BMC Infectious Diseases, 24(1), 1–7. https://doi.org/10.1186/s12879-024-10107-7

Chicago

Waked, Rami, Leslie Coats, Adriana Rosato, Christina F. Yen, Emily Wood, Daniel J. Diekema, Kristina E. Rokas, and Nicholas J. Mercuro. 2024. “Clinical Outcome of Combination of Vancomycin and Ceftaroline versus Vancomycin Monotherapy for Treatment of Methicillin Resistant Staphylococcus Aureus Bloodstream Infection.” BMC Infectious Diseases 24 (1): 1–7. doi:10.1186/s12879-024-10107-7.